Insta
With No Side-Effects, Herbal Drug Used By Tribals Passes AIIMS Delhi Trials For Treating Superficial Wounds
AIIMS Delhi (Glassdoor/AIIMS)
In a major boost for the application of Ayurvedic drugs in India, the nation's premier medical institution All India Institute of Medical Sciences (AIIMS) in collaboration with the Ministry of AYUSH completed the first phase of an herbal drug trial to treat superficial wounds, reports Indian Express.
The said drug, AYUSH C1 Oil, which is commonly used by tribal populations to treat wounds, has been tried on 30 patients who visited AIIMS. As per doctors, the results were found to be effective with zero side effects.
The drug was identified by the Ministry of AYUSH, and then trials for the same were launched in 2015-16. Now that the first phase of the trials have been completed, the AIIMS is to submit a report of the same to the Ministry of AYUSH.
The trials were conducted under the department of plastic, reconstructive and burns surgery, AIIMS. Its Dr Maneesh Singhal said, "If we measure the results of normal remedy with this herbal drug treatment, then the result of the latter is a notch better. No patient has complained of any problem.”
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
